These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 9130522
1. Eosinophil granule proteins are selective activators of human heart mast cells. Patella V, de Crescenzo G, Marino I, Genovese A, Adt M, Gleich GJ, Marone G. Int Arch Allergy Immunol; 1997; 113(1-3):200-2. PubMed ID: 9130522 [Abstract] [Full Text] [Related]
2. Eosinophil granule proteins activate human heart mast cells. Patella V, de Crescenzo G, Marinò I, Genovese A, Adt M, Gleich GJ, Marone G. J Immunol; 1996 Aug 01; 157(3):1219-25. PubMed ID: 8757629 [Abstract] [Full Text] [Related]
3. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. Okayama Y, el-Lati SG, Leiferman KM, Church MK. J Allergy Clin Immunol; 1994 May 01; 93(5):900-9. PubMed ID: 7514197 [Abstract] [Full Text] [Related]
4. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. Zheutlin LM, Ackerman SJ, Gleich GJ, Thomas LL. J Immunol; 1984 Oct 01; 133(4):2180-5. PubMed ID: 6206154 [Abstract] [Full Text] [Related]
5. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Ackerman SJ, Gleich GJ, Loegering DA, Richardson BA, Butterworth AE. Am J Trop Med Hyg; 1985 Jul 01; 34(4):735-45. PubMed ID: 4025686 [Abstract] [Full Text] [Related]
6. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Trocmé SD, Hallberg CK, Gill KS, Gleich GJ, Tyring SK, Brysk MM. Invest Ophthalmol Vis Sci; 1997 Mar 01; 38(3):593-9. PubMed ID: 9071212 [Abstract] [Full Text] [Related]
7. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. Hamann KJ, Gleich GJ, Checkel JL, Loegering DA, McCall JW, Barker RL. J Immunol; 1990 Apr 15; 144(8):3166-73. PubMed ID: 2324497 [Abstract] [Full Text] [Related]
8. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. Ackerman SJ, Loegering DA, Venge P, Olsson I, Harley JB, Fauci AS, Gleich GJ. J Immunol; 1983 Dec 15; 131(6):2977-82. PubMed ID: 6644025 [Abstract] [Full Text] [Related]
9. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. Davis MD, Plager DA, George TJ, Weiss EA, Gleich GJ, Leiferman KM. J Allergy Clin Immunol; 2003 Nov 15; 112(5):988-94. PubMed ID: 14610493 [Abstract] [Full Text] [Related]
10. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. J Immunol; 1995 May 01; 154(9):4749-58. PubMed ID: 7722326 [Abstract] [Full Text] [Related]
11. Eosinophil granule proteins in peripheral blood granulocytes. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, Gleich GJ. J Leukoc Biol; 1992 Dec 01; 52(6):611-8. PubMed ID: 1464733 [Abstract] [Full Text] [Related]
12. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Motojima S, Frigas E, Loegering DA, Gleich GJ. Am Rev Respir Dis; 1989 Mar 01; 139(3):801-5. PubMed ID: 2923379 [Abstract] [Full Text] [Related]
13. Polymorphic eruption of pregnancy and herpes gestationis: comparison of granulated cell proteins in tissue and serum. Borrego L, Peterson EA, Diez LI, de Pablo Martin P, Wagner JM, Gleich GJ, Leiferman KM. Clin Exp Dermatol; 1999 May 01; 24(3):213-25. PubMed ID: 10354184 [Abstract] [Full Text] [Related]
14. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. Hamann KJ, Barker RL, Loegering DA, Gleich GJ. J Parasitol; 1987 Jun 01; 73(3):523-9. PubMed ID: 3598802 [Abstract] [Full Text] [Related]
15. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. Barker RL, Loegering DA, Ten RM, Hamann KJ, Pease LR, Gleich GJ. J Immunol; 1989 Aug 01; 143(3):952-5. PubMed ID: 2745977 [Abstract] [Full Text] [Related]
16. [Biochemistry and biological activities of eosinophil granule proteins]. Enokihara H, Koike T. Nihon Rinsho; 1993 Mar 01; 51(3):605-12. PubMed ID: 7684096 [Abstract] [Full Text] [Related]
17. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation. Gruart V, Truong MJ, Plumas J, Zandecki M, Kusnierz JP, Prin L, Vinatier D, Capron A, Capron M. Blood; 1992 May 15; 79(10):2592-7. PubMed ID: 1375105 [Abstract] [Full Text] [Related]
18. Eosinophil ribonucleases and their cutaneous lesion-forming activity. Plager DA, Davis MD, Andrews AG, Coenen MJ, George TJ, Gleich GJ, Leiferman KM. J Immunol; 2009 Sep 15; 183(6):4013-20. PubMed ID: 19717523 [Abstract] [Full Text] [Related]
19. Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins. Makiya MA, Herrick JA, Khoury P, Prussin CP, Nutman TB, Klion AD. J Immunol Methods; 2014 Sep 15; 411():11-22. PubMed ID: 24914990 [Abstract] [Full Text] [Related]
20. Stem cell factor influences mast cell mediator release in response to eosinophil-derived granule major basic protein. Furuta GT, Ackerman SJ, Lu L, Williams RE, Wershil BK. Blood; 1998 Aug 01; 92(3):1055-61. PubMed ID: 9680375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]